MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lin, Y. F.
Right arrow Articles by Macdonald, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lin, Y. F.
Right arrow Articles by Macdonald, R. L.

Enhancement of recombinant alpha 1 beta 1 gamma 2L gamma-aminobutyric acidA receptor whole-cell currents by protein kinase C is mediated through phosphorylation of both beta 1 and gamma 2L subunits

YF Lin, TP Angelotti, EM Dudek, MD Browning and RL Macdonald

Department of Physiology, University of Michigan Medical School, Ann Arbor 48109, USA.

The gamma-aminobutyric acidA (GABA)A receptor (GABAR) beta 1 and gamma 2L subtypes have been shown to be phosphorylated in vitro by protein kinase C (PKC) [J. Biol. Chem. 267:14470-14476 (1992); Neuron 12:1081- 1095 (1994)]. To determine the physiological consequences of phosphorylation of GABAR isoforms containing the beta 1 and gamma 2L subtypes, the specific serine residues phosphorylated by PKC (beta 1 S409, gamma 2L S327 and S343) were changed to alanines through site- directed mutagenesis. Wild-type (alpha 1 beta 1 gamma 2L GABARs) and three mutant GABAR isoforms [alpha 1 beta 1 gamma 2L(S327A, S343A), alpha 1 beta 1(S409A) gamma 2L, and alpha 1 beta 1(S409A) gamma 2L(S327A, S343A) GABARs) were expressed in mouse L929 fibroblasts through transient cotransfection. Recordings were obtained from each cell with the use of the whole-cell patch-clamp technique. The initial recording was made with the use of control intrapipette solution, and a second recording from the same cell was obtained with pipettes containing either constitutively active PKC [protein kinase M (PKM)] or control solution to obtain paired GABA concentration-response relationships. All GABAR isoforms studied had equivalent maximal GABA currents and similar GABA concentration-response profiles under the control condition. Intracellular PKM treatment increased the maximal current and EC50 value in cells expressing wild-type GABARs. However, PKM reimpalement did not significantly change these parameters in cells expressing any of the mutant GABAR isoforms, indicating that the mutation of either the beta 1 or gamma 2L subtype alone was sufficient to prevent enhancement of GABAR current by PKM. No significant changes were obtained during control reimpalement recordings of wild-type or mutant receptors. Furthermore, PKM treatment did not after the time constants of GABA current desensitization kinetics measured from cells expressing wild-type or mutant receptors. These data thus suggest that PKC phosphorylation of the beta 1 and gamma 2L subtypes enhances GABAR current and that both subtypes are required for complete PKC-mediated enhancement of alpha 1 beta 1 gamma 2L GABAR current.

Volume 50, Issue 1, pp. 185-195, 07/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
C. M. Houston, H. H. C. Lee, A. M. Hosie, S. J. Moss, and T. G. Smart
Identification of the Sites for CaMK-II-dependent Phosphorylation of GABAA Receptors
J. Biol. Chem., June 15, 2007; 282(24): 17855 - 17865.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Palma, D. A. Ragozzino, S. Di Angelantonio, G. Spinelli, F. Trettel, A. Martinez-Torres, G. Torchia, A. Arcella, G. Di Gennaro, P. P. Quarato, et al.
Phosphatase inhibitors remove the run-down of {gamma}-aminobutyric acid type A receptors in the human epileptic brain
PNAS, July 6, 2004; 101(27): 10183 - 10188.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. N. Jovanovic, P. Thomas, J. T. Kittler, T. G. Smart, and S. J. Moss
Brain-Derived Neurotrophic Factor Modulates Fast Synaptic Inhibition by Regulating GABAA Receptor Phosphorylation, Activity, and Cell-Surface Stability
J. Neurosci., January 14, 2004; 24(2): 522 - 530.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Wang, S. Liu, U. Haditsch, W. Tu, K. Cochrane, G. Ahmadian, L. Tran, J. Paw, Y. Wang, I. Mansuy, et al.
Interaction of Calcineurin and Type-A GABA Receptor gamma 2 Subunits Produces Long-Term Depression at CA1 Inhibitory Synapses
J. Neurosci., February 1, 2003; 23(3): 826 - 836.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
B. K. Hoffpauir and E. L. Gleason
Activation of mGluR5 Modulates GABAA Receptor Function in Retinal Amacrine Cells
J Neurophysiol, October 1, 2002; 88(4): 1766 - 1776.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. J. Brandon, J. N. Jovanovic, T. G. Smart, and S. J. Moss
Receptor for Activated C Kinase-1 Facilitates Protein Kinase C-Dependent Phosphorylation and Functional Modulation of GABAA Receptors with the Activation of G-Protein-Coupled Receptors
J. Neurosci., August 1, 2002; 22(15): 6353 - 6361.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
G. Hapfelmeier, W. Zieglgansberger, R. Haseneder, H. Schneck, and E. Kochs
Nitrous Oxide and Xenon Increase the Efficacy of GABA at Recombinant Mammalian GABAA Receptors
Anesth. Analg., December 1, 2000; 91(6): 1542 - 1549.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Fancsik, D. M. Linn, and J. G. Tasker
Neurosteroid Modulation of GABA IPSCs Is Phosphorylation Dependent
J. Neurosci., May 1, 2000; 20(9): 3067 - 3075.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. Filippova, A. Sedelnikova, Y. Zong, H. Fortinberry, and D. S. Weiss
Regulation of Recombinant gamma -Aminobutyric Acid (GABA)A and GABAC Receptors by Protein Kinase C
Mol. Pharmacol., May 1, 2000; 57(5): 847 - 856.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
S. Wang, Q. Cheng, S. Malik, and J. Yang
Interleukin-1beta Inhibits gamma -Aminobutyric Acid Type A (GABAA) Receptor Current in Cultured Hippocampal Neurons
J. Pharmacol. Exp. Ther., February 1, 2000; 292(2): 497 - 504.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
N. J. Brandon, J. M. Uren, J. T. Kittler, H. Wang, R. Olsen, P. J. Parker, and S. J. Moss
Subunit-Specific Association of Protein Kinase C and the Receptor for Activated C Kinase with GABA Type A Receptors
J. Neurosci., November 1, 1999; 19(21): 9228 - 9234.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Kannenberg, M. T. Schaerer, K. Fuchs, W. Sieghart, and E. Sigel
A Novel Serine Kinase with Specificity for beta 3-Subunits Is Tightly Associated with GABAA Receptors
J. Biol. Chem., July 23, 1999; 274(30): 21257 - 21264.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
H. K. Gershenfeld, P. E. Neumann, X. Li, P. L. St. Jean, and S. M. Paul
Mapping Quantitative Trait Loci for Seizure Response to a GABAA Receptor Inverse Agonist in Mice
J. Neurosci., May 15, 1999; 19(10): 3731 - 3738.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R.-Q. Huang and G. H. Dillon
Maintenance of Recombinant Type A gamma -Aminobutyric Acid Receptor Function: Role of Protein Tyrosine Phosphorylation and Calcineurin
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 243 - 255.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
R. F. Tyndale, S. V. Bhave, E. Hoffmann, P. L. Hoffman, B. Tabakoff, A. J. Tobin, and R. W. Olsen
Pentobarbital Decreases the gamma -Aminobutyric AcidA Receptor Subunit gamma-2 Long/Short mRNA Ratio by a Mechanism Distinct from Receptor Occupation
J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 350 - 357.
[Abstract] [Full Text]


Home page
J. Neurosci.Home page
Q. Wan, H. Y. Man, J. Braunton, W. Wang, M. W. Salter, L. Becker, and Y. T. Wang
Modulation of GABAA Receptor Function by Tyrosine Phosphorylation of beta  Subunits
J. Neurosci., July 1, 1997; 17(13): 5062 - 5069.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. J. Brandon, P. Delmas, J. T. Kittler, B. J. McDonald, W. Sieghart, D. A. Brown, T. G. Smart, and S. J. Moss
GABAA Receptor Phosphorylation and Functional Modulation in Cortical Neurons by a Protein Kinase C-dependent Pathway
J. Biol. Chem., December 1, 2000; 275(49): 38856 - 38862.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. T. Schaerer, K. Kannenberg, P. Hunziker, S. W. Baumann, and E. Sigel
Interaction between GABAA Receptor beta Subunits and the Multifunctional Protein gC1q-R
J. Biol. Chem., July 6, 2001; 276(28): 26597 - 26604.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Martinez-Torres, A. Demuro, and R. Miledi
GABArho 1/GABAAalpha 1 receptor chimeras to study receptor desensitization
PNAS, March 28, 2000; 97(7): 3562 - 3566.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics